Stock Markets March 2, 2026 02:01 PM

Market Movers: Palantir, RTX Advance While AeroVironment and AES Slip

A cross-capitalization snapshot shows technology and semiconductor names rising as select defense and energy stocks decline amid program and corporate-deal developments

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
PLTR RTX NVDA ORCL LLY

Stocks across market-cap segments displayed notable intraday volatility on Monday. Mega-cap technology names such as Palantir Technologies and Nvidia posted gains, while several large- and small-cap names experienced double-digit moves tied to analyst actions, corporate transactions and quarterly results. The session featured a mix of program-related downgrades, an announced buyout, and targeted strategic investments that coincided with sharp share-price reactions.

Market Movers: Palantir, RTX Advance While AeroVironment and AES Slip
PLTR RTX NVDA ORCL LLY
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Technology and semiconductor investments and earnings supported gains for several large and mid-cap names, including Palantir, Nvidia, Coherent and Lumentum.
  • Defense-program and buyout-related developments led to sharp declines for certain large-cap names, notably AeroVironment and AES.
  • Biotech and small-cap healthcare stocks showed pronounced volatility, with uniQure falling after a downgrade tied to an FDA setback.

Stocks moved decisively across market-cap categories on Monday, with winners and losers clustered around company-specific news and transactional updates. Technology and semiconductor equities were among the gainers, while firms tied to defense programs and an announced energy-sector buyout registered significant declines.


Mega-cap highlights (market cap: $200B+)

  • Palantir Technologies Inc (PLTR) rose 5.95%.
  • United Tech (RTX) advanced 4.18%.
  • Nvidia Corp (NVDA) climbed 2.77%.
  • Oracle Corp (ORCL) increased 2.13%.
  • Eli Lilly And Co (LLY) fell 2.45%.
  • Home Depot (HD) declined 2.88%.

Large-cap movers (market cap: $10B-$200B)

Several large-cap stocks experienced substantial intraday swings tied to analyst commentary, corporate transactions and earnings updates:

  • AeroVironment (AVAV) dropped 19.43% after Raymond James lowered its rating citing risk associated with the SCAR program.
  • AES Corp (AES) fell 17.33% following an agreement for a $10.7 billion buyout by a GIP-EQT consortium.
  • Venture Global Inc (VG) jumped 13.88% after reporting a fourth-quarter earnings beat.
  • Coherent (COHR) surged 13.59% as Nvidia committed a $2 billion investment and a multibillion-dollar purchase agreement.
  • Circle Internet Group Inc (CRCL) added 13.23%.
  • Kaspi.kz AO ADR (KSPI) rose 9.77%.
  • Tower Semiconductor (TSEM) climbed 10.57%.
  • NantKwest (IBRX) was up 8.74%.
  • Norwegian Cruise Line Holdings Ltd (NCLH) dropped 10.55%.
  • Lumentum Holdings Inc (LITE) gained 8.41% after Nvidia invested $2 billion in Lumentum for AI optics technology.

Mid-cap movers (market cap: $2B-$10B)

  • Evolution Metals Tech (EMAT) jumped 32.37%.
  • Applied Opt (AAOI) rose 21.48%.
  • AXT Inc (AXTI) increased 19.0%.
  • Arcus Biosciences Inc (RCUS) climbed 19.07%.
  • nLIGHT Inc (LASR) added 17.85%.
  • Turning Point Brands Inc (TPB) slid 18.43%.
  • Figure Technology Solutions Ltd (FIGR) rose 16.89%.
  • SOLT (SOLT) climbed 14.37%.
  • Jds Uniphase Corp (VIAV) advanced 17.2%.
  • SolarEdge Technologies Inc (SEDG) increased 11.05%.

Small-cap movers (market cap: $300M-$2B)

Small-cap stocks recorded some of the most pronounced percentage moves during the session:

  • Uniqure Nv (QURE) plunged 34.1% after Cantor Fitzgerald downgraded the stock, citing an FDA setback.
  • Sabre Corpo (SABR) surged 32.2%.
  • Apollo Medical (ASTH) rose 25.28% as Astrana Health stock moved higher following an earnings beat and stronger guidance.
  • Mri Interventions (CLPT) fell 21.56%.
  • Ocular Therapeutix Inc (OCUL) added 18.79%.
  • TimefireVR (RCAT) gained 17.51%.
  • Hyperliquid Strategies (PURR) increased 17.89%.
  • Junee (SUPX) declined 18.6%.
  • United States Antimony Corp (UAMY) climbed 18.01%.
  • Goodrx Holdings Inc (GDRX) was up 15.64%.

Takeaways

The session underscored active rotation within the market: technology and semiconductor-related names benefited from targeted investments and earnings beats, while stocks exposed to program risk and pending corporate transactions experienced steep declines. Movements ranged from modest gains among mega-cap tech firms to sharp, double-digit swings in small- and mid-cap names.


Key points

  • Technology and semiconductor sectors showed strength, supported by strategic investments and earnings beats that corresponded with share-price gains for companies like Coherent, Lumentum, Nvidia and Palantir.
  • Defense and energy-related names faced pressure; AeroVironment dropped after a downgrade tied to the SCAR program risk, while AES fell following an announced $10.7 billion buyout by a GIP-EQT consortium.
  • Biotech and small-cap healthcare names exhibited high volatility, exemplified by uniQure's steep decline after an FDA-related downgrade and mixed results elsewhere in the group.

Risks and uncertainties

  • Analyst downgrades can trigger abrupt share-price declines for companies tied to program or regulatory risk - as shown by Raymond James' action on AeroVironment and Cantor Fitzgerald's downgrade of uniQure; these events affect defense and biotechnology sectors.
  • Corporate transactions, including buyout agreements, may depress the target's public shares during the announcement period - illustrated by AES after the $10.7 billion buyout agreement; the energy sector is particularly implicated.
  • Market reactions to large, company-specific investments and purchase commitments - such as Nvidia's multibillion engagements with Coherent and Lumentum - can drive concentrated gains in technology and semiconductor-related equities, but also increase volatility within those sectors.

This piece presents a snapshot of intraday price movements across a range of market-cap segments and does not provide investment advice.

Risks

  • Analyst downgrades tied to program risk or regulatory setbacks can cause steep share-price declines, impacting defense and biotechnology sectors.
  • Announced buyouts or large corporate transactions may depress target-company shares during the announcement and negotiation phase, affecting energy-sector valuations.
  • Concentrated strategic investments and purchase commitments can amplify volatility in technology and semiconductor-related equities.

More from Stock Markets

Options on SpaceX Expected to Draw Heavy, Volatile Trading When Listed This Week Jun 14, 2026 Analyst Calls Roundup: Upgrades Highlight Turnarounds, Biotech Momentum, Defense Tailwinds; SpaceX Draws Caution Jun 14, 2026 Wall Street Reprices AI Winners: Big Upgrades for Intel, Micron and STMicro; SpaceX Rated Buy Ahead of IPO Jun 14, 2026 How Booking Built Dominance in Online Hotel Bookings and the AI Question Looming Over Its Lead Jun 14, 2026 SpaceX IPO Lifts Risk Appetite as Markets Close Out a Turbulent Week Jun 13, 2026